Literature DB >> 18419417

Varicella among adults: data from an active surveillance project, 1995-2005.

Mona Marin1, Tureka L Watson, Sandra S Chaves, Rachel Civen, Barbara M Watson, John X Zhang, Dana Perella, Laurene Mascola, Jane F Seward.   

Abstract

We report detailed population-based data on varicella among adults. In 2 US varicella active surveillance sites with high vaccine coverage among young children, the incidence of varicella among adults declined 74% during 1995-2005. A low proportion (3%) of adults with varicella had been vaccinated, with no improvement over the decade of program implementation, suggesting that the decline was likely secondary to herd-immunity effects. Compared with children, adults had more severe varicella in terms of both clinical presentation and frequency of complications. However, <30% of adults with varicella were treated with acyclovir. Among adolescents, illness severity was intermediate between that in children and adults. Varicella cases are preventable through vaccination. As we enter the second decade of the varicella vaccination program in the United States, we need to ensure that susceptible adolescents and adults are adequately protected from varicella by vaccination and that those who acquire varicella are appropriately treated with effective antiviral treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18419417     DOI: 10.1086/522155

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  32 in total

1.  Varicella reinfection in a seropositive physician following occupational exposure to localized zoster.

Authors:  Jennifer A Johnson; Karen C Bloch; Bich N Dang
Journal:  Clin Infect Dis       Date:  2011-01-27       Impact factor: 9.079

2.  A varicella outbreak in a school with high one-dose vaccination coverage, Beijing, China.

Authors:  Li Lu; Luodan Suo; Juan Li; Lijun Zhai; Qingxiu Zheng; Xinghuo Pang; Stephanie R Bialek; Chengbin Wang
Journal:  Vaccine       Date:  2012-06-09       Impact factor: 3.641

3.  Maritime varicella illness and death reporting, U.S., 2010-2015.

Authors:  Marion E Rice; Millicent Bannerman; Mona Marin; Adriana S Lopez; Melissa M Lewis; Caroline E Stamatakis; Joanna J Regan
Journal:  Travel Med Infect Dis       Date:  2018-04-03       Impact factor: 6.211

4.  Health status of newly arrived refugees in Toronto, Ont: Part 1: infectious diseases.

Authors:  Vanessa J Redditt; Praseedha Janakiram; Daniela Graziano; Meb Rashid
Journal:  Can Fam Physician       Date:  2015-07       Impact factor: 3.275

Review 5.  Successes and challenges in varicella vaccine.

Authors:  Orestis Papaloukas; Georgia Giannouli; Vassiliki Papaevangelou
Journal:  Ther Adv Vaccines       Date:  2014-03

6.  Varicella bullosa in an adult.

Authors:  Preema Sinha; Saikat Bhattacharjee; Manas Chatterjee
Journal:  Med J Armed Forces India       Date:  2016-12-01

7.  Determining the persistence of maternally acquired antibodies to hepatitis A and varicella zoster during the first 2 years of life in Turkey.

Authors:  Fırat Begde; Filiz Simsek Orhon; Devran Gerceker; Betul Ulukol; Seda Topcu; Sevgi Baskan
Journal:  Eur J Pediatr       Date:  2015-01-07       Impact factor: 3.183

8.  Safety and immunogenicity of Bio Pox™, a live varicella vaccine (Oka strain) in Indian children: A comparative multicentric, randomized phase II/III clinical trial.

Authors:  Anand Prakash Dubey; Mohammad Moonis Akbar Faridi; Monjori Mitra; Iqbal Rajinder Kaur; Aashima Dabas; Jaydeep Choudhury; Mallar Mukherjee; Devendra Mishra
Journal:  Hum Vaccin Immunother       Date:  2017-05-16       Impact factor: 3.452

9.  Immunogenicity and safety of different schedules of 2-dose varicella vaccination in China.

Authors:  Xuan Deng; Wenqing Xu; Rui Yan; Haiping Chen; Wei Shen; Min Zhang; Tengjie Wu; Bin Xu; Hanqing He; Yanli Ma
Journal:  Hum Vaccin Immunother       Date:  2016-07-25       Impact factor: 3.452

Review 10.  A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24-25 July 2008.

Authors:  Judith Breuer; Charles Grose; Peter Norberg; Graham Tipples; D Scott Schmid
Journal:  J Gen Virol       Date:  2010-01-13       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.